Ascend Wellness Holdings (AAWH) Total Current Liabilities (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Total Current Liabilities of $88.5 million for Q1 2026, down 40.2% year-over-year from $147.9 million in Q1 2025, and down 18.85% quarter-over-quarter from $109.0 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Total Current Liabilities (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $88.5 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 40.2% year-over-year to $88.5 million; the TTM figure through Mar 2026 stood at $88.5 million (down 40.2% YoY), while the FY2025 annual figure was $109.0 million, down 24.58% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $88.5 million, down from $109.0 million in the prior quarter.
- The five-year high for Total Current Liabilities was $147.9 million in Q1 2025, with the low at $88.5 million in Q1 2026.
- The 5-year median for Total Current Liabilities is $109.8 million (2023), against an average of $116.2 million.
- The sharpest annual moves came in 2024 and 2026: Total Current Liabilities jumped 55.95% in 2024, then tumbled 40.2% in 2026.
- Ascend Wellness Holdings' Total Current Liabilities stood at $110.9 million in 2022, then decreased by 16.46% to $92.7 million in 2023, then surged by 55.95% to $144.5 million in 2024, then retreated by 24.58% to $109.0 million in 2025, then retreated by 18.85% to $88.5 million in 2026.
- Business Quant data shows AAWH's Total Current Liabilities at $88.5 million in Q1 2026, $109.0 million in Q4 2025, and $96.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.79 Bn |
| 10 | Ascend Wellness Holdings | 95.41 Mn | 28.41 Mn | 45.49 Mn | 112.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 112.64 Mn |
| Mar 31, 2026 | 88.46 Mn |
| Dec 31, 2025 | 109.01 Mn |
| Sep 30, 2025 | 96.00 Mn |
| Jun 30, 2025 | 100.79 Mn |
| Mar 31, 2025 | 147.92 Mn |
| Dec 31, 2024 | 144.54 Mn |
| Sep 30, 2024 | 145.13 Mn |
| Jun 30, 2024 | 103.06 Mn |
| Mar 31, 2024 | 103.44 Mn |
| Dec 31, 2023 | 92.69 Mn |
| Sep 30, 2023 | 129.76 Mn |
| Jun 30, 2023 | 124.65 Mn |
| Mar 31, 2023 | 109.81 Mn |
| Dec 31, 2022 | 110.95 Mn |
| Sep 30, 2022 | 137.50 Mn |
| Jun 30, 2022 | 122.04 Mn |
| Mar 31, 2022 | 109.33 Mn |
| Dec 31, 2021 | 117.40 Mn |
| Sep 30, 2021 | 104.89 Mn |